ABT-510 acetate
ABT-510 acetate is an endogenous anti-angiogenic TSP peptide inhibitor, a thrombospondin analog, with anti-inflammatory, anti-cancer and anti-angiogenic activity that induces apoptosis and inhibits ovarian tumor growth in an orthotopic, syngeneic model of epithelial ovarian cancer.ABT-510 acetate reduces angiogenesis and inflammatory responses in a mouse model of inflammatory bowel disease. ABT-510 acetate reduces angiogenesis and inflammation in mouse models of inflammatory bowel disease (IBD) and can be used in cancer research, particularly in epithelial ovarian cancer, as well as in inflammatory bowel disease (IBD) .
Product Specifications
CAS Number
442526-87-6
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
1054.28
Molecular Formula
C48H87N13O13
Notes
Research use only, not for human use.
Receptor
Apoptosis
Available Sizes
Explore Other Products
Browse additional items from our catalog